GLPwatch
Trials (2101)
Page 19 of 36.
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
- A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
- High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
- Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- A Study of Tirzepatide in Overweight and Very Overweight Participants
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
- Exenatide for Treating Cocaine Use Disorder
- WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
- Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
- A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
- Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
- Effects of GH and Lirglutide on AgRP
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
- A Study of BGM0504 in Participants with Type 2 Diabetes
- Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- Treatment of Bile Acid Malabsorption With Liraglutide
- A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
- A Study of IBI362 in Participants With Obesity or Overweight
- Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
- A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
- A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
- A Phase 3 Study of HS-20094 in Patients With T2DM
- Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes